JONATHON KORTH: Open Payments
NPI 1942925516 · HUMPHREY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 21 payments from 14 companies in 2025. Trend: 2023 $231 · 2024 $331 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $30 |
| Dexcom, Inc. | 2 | $28 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: REXULTI, EVENITY, Dexcom G6 Transmitter, FUROSCIX, ARISTADA, AUSTEDO XR, FARXIGA, UZEDY.
Industry payments across NE — which companies pay providers there.
